{"url":"https://lda.senate.gov/api/v1/filings/97b0efa1-dc2e-4b8e-b4be-08932e46042e/","filing_uuid":"97b0efa1-dc2e-4b8e-b4be-08932e46042e","filing_type":"RR","filing_type_display":"Registration","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/97b0efa1-dc2e-4b8e-b4be-08932e46042e/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David Friedman","dt_posted":"2025-12-17T16:12:41-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2332 Galiano St","registrant_address_2":"2nd Floor","registrant_different_address":null,"registrant_city":"Coral Gables","registrant_state":"FL","registrant_zip":"33134","registrant":{"id":401110165,"url":"https://lda.senate.gov/api/v1/registrants/401110165/","house_registrant_id":77353,"name":"MR. DAVID FRIEDMAN","description":null,"address_1":"2332 Galiano St","address_2":"2nd Floor","address_3":null,"address_4":null,"city":"Coral Gables","state":"FL","state_display":"Florida","zip":"33134","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID FRIEDMAN","contact_telephone":"+1 202-737-8808","dt_updated":"2026-07-17T14:31:22.573504-04:00"},"client":{"id":70210,"url":"https://lda.senate.gov/api/v1/clients/70210/","client_id":70210,"name":"TEVA PHARMACEUTICALS USA, INC.","general_description":"Pharmaceutical manufacturer.","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-11-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to strengthening the domestic supply and manufacture of essential medicines.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152228,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"FRIEDMAN","suffix":null,"suffix_display":null},"covered_position":"United States Ambassador to Israel, 2017-2021","new":true}],"government_entities":[]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Issues related to strengthening the domestic supply and manufacture of essential medicines.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":152228,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"FRIEDMAN","suffix":null,"suffix_display":null},"covered_position":"United States Ambassador to Israel, 2017-2021","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"TEVA PHARMACEUTICAL INDUSTRIES LTD.","contribution":"0.00","ownership_percentage":"100.00","address":"124 Dvora HaNevi'a St.","city":"Tel Aviv","state":null,"state_display":null,"country":"IL","country_display":"Israel","ppb_city":"Tel Aviv","ppb_state":null,"ppb_state_display":null,"ppb_country":"IL","ppb_country_display":"Israel"}],"affiliated_organizations":[]}